Pearl Therapeutics Logo
Pearl Therapeutics Issued U.S. Patent on Co-Suspension Formulation Technology
December 05, 2012 08:00 ET | Pearl Therapeutics
REDWOOD CITY, CALIF., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the U.S. Patent and Trademark Office has issued a patent on its novel co-suspension formulation...
Pearl Therapeutics Logo
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
November 13, 2012 07:30 ET | Pearl Therapeutics
REDWOOD CITY, CALIF, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced a $65 million Series D financing raised from current investors. 5AM Ventures, Clarus Ventures and...
Do More With Oxygen Offers Free Guides to Assist Portable Oxygen Users and Those Affected by COPD
November 09, 2012 11:35 ET | Do More With Oxygen
CLEVELAND, OH--(Marketwire - Nov 9, 2012) - Do More With Oxygen, an online community for those affected by Chronic Obstructive Pulmonary Disease (COPD), released two new guides to better assist...
Do More With Oxygen, an Online Community for Those Affected by COPD, Offers Guidance for Caregivers
August 24, 2012 10:04 ET | Do More With Oxygen
CLEVELAND, OH--(Marketwire - Aug 24, 2012) - Caregivers with loved ones who suffer from respiratory ailments like Chronic Obstructive Pulmonary Disease (COPD) can now find help for providing care...
P2D Bioscience Receives NIH Funding to Develop Drugs for Lung Disease
July 19, 2011 10:31 ET | P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jul 19, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, announced today that the company has received a $320,000 grant from...